Synopsis: Oberoi Realty, Dabur India, Alkem Laboratories, P&G Hygiene and Health Care, ICICI Prudential Life Insurance, and M&M Financial Services are trading below their 5-year median P/E, indicating potential undervaluation, reasonable valuations, and selective growth opportunities across mid-cap segments.
Undervalued mid-cap stocks are those trading at a price-to-earnings (P/E) ratio lower than both their industry average and their own 5-year median P/E. This suggests the market may be underpricing their true potential despite stable fundamentals. Such stocks often present attractive investment opportunities, as they combine reasonable valuations with the possibility of future growth, margin expansion, and earnings improvement once market sentiment or business performance strengthens over time. Here are a few undervalued Mid-cap stocks that are trading below their 5-year median P/E ratio
Oberoi Realty Limited
With a market capitalization of Rs. 61,757.84 crore, the shares of Oberoi Realty Limited closed at Rs. 1,698.50 per equity share, rising nearly 1.49 percent from its previous day’s close price of Rs. 1,673.55.
Oberoi Realty Limited trades at a price-to-earnings ratio of 27.4, significantly below the industry average of 28.1, indicating potential undervaluation compared to peers in its sector. The company’s price-to-earnings is also lower than its 3-year and 5-year average PE of 27.8, indicating a valuation discount.
Oberoi Realty Limited is a publicly listed real estate development company headquartered in Mumbai, India. Established in 1998, it is among India’s leading luxury property developers, with operations spanning residential, commercial, retail, hospitality, and social infrastructure projects. The company is recognized for reshaping Mumbai’s skyline through its high-end mixed-use developments and design-led approach to urban living.
Alkem Laboratories Limited
With a market capitalization of Rs. 66,561.84 crore, the shares of Alkem Laboratories Limited closed at Rs. 5,567 per equity share, down nearly 0.43 percent from its previous day’s close price of Rs. 5,590.85.
Alkem Laboratories Limited trades at a price-to-earnings ratio of 27.7, significantly below the industry average of 31.4, indicating potential undervaluation compared to peers in its sector. The company’s price-to-earnings is also lower than its 3-year average PE of 31 and significantly below its 5-year average PE of 29, indicating a valuation discount.
Alkem Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra. It develops, manufactures, and markets branded generics, formulations, and active pharmaceutical ingredients (APIs). The firm is among India’s top drugmakers by domestic sales and has a significant global footprint in over 50 countries.
Procter & Gamble Hygiene and Health Care Limited
With a market capitalization of Rs. 32,330.89 crore, the shares of Procter & Gamble Hygiene and Health Care Limited closed at Rs. 9,960 per equity share, rising nearly 0.67 percent from its previous day’s close price of Rs. 9,893.50.
Procter & Gamble Hygiene and Health Care Limited trades at a price-to-earnings ratio of 37.6, significantly below the industry average of 44, indicating potential undervaluation compared to peers in its sector. The company’s price-to-earnings is also lower than its 3-year average PE of 70.2 and significantly below its 5-year average PE of 74.7, indicating a valuation discount.
Procter & Gamble Hygiene and Health Care Limited (P&GHH) is an Indian subsidiary of The Procter & Gamble Company, engaged in the manufacture and marketing of branded fast-moving consumer goods (FMCG). Headquartered in Mumbai, it plays a leading role in India’s hygiene and healthcare categories through its flagship brands Whisper and Vicks.
Mahindra & Mahindra Financial Services Limited
With a market capitalization of Rs. 46,723.88 crore, the shares of Mahindra & Mahindra Financial Services Limited closed at Rs. 336.15 per equity share, rising nearly 2.34 percent from its previous day’s close price of Rs. 328.45.
Mahindra & Mahindra Financial Services Limited trades at a price-to-earnings ratio of 15.8, significantly below the industry average of 19.7, indicating potential undervaluation compared to peers in its sector. The company’s price-to-earnings is also lower than its 3-year average PE of 18.1 and significantly below its 5-year average PE of 18.1, indicating a valuation discount.
Mahindra & Mahindra Financial Services Limited (Mahindra Finance) is a major Indian non-banking financial company (NBFC) headquartered in Mumbai. Part of the Mahindra Group, it provides financing, insurance, and investment solutions focused primarily on rural and semi-urban markets, enabling financial inclusion for millions of underserved customers.
ICICI Prudential Life Insurance Company Limited
With a market capitalization of Rs. 82,051 crore, the shares of ICICI Prudential Life Insurance Company Limited closed at Rs. 565.80 per equity share, rising nearly 0.57 percent from its previous day’s close price of Rs. 562.60.
ICICI Prudential Life Insurance Company Limited trades at a price-to-earnings ratio of 51, significantly below the industry average of 73.3, indicating potential undervaluation compared to peers in its sector. The company’s price-to-earnings is also lower than its 3-year average PE of 84.4 and significantly below its 5-year average PE of 87, indicating a valuation discount.
ICICI Prudential Life Insurance Company Limited is a leading Indian private sector life insurer headquartered in Mumbai. It is a joint venture between ICICI Bank Limited and Prudential plc, providing life insurance, savings, and protection products to individuals and groups across India.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post 5 Undervalued Mid-Cap Stocks Trading Below Their 5-Year Median PE Ratio appeared first on Trade Brains.
Original Article
(Disclaimer – This post is auto-fetched from publicly available RSS feeds. Original source: Tradebrains. All rights belong to the respective publisher.)
